Evidence map›Paper›PMID 40830840›Full record

ArticleBMC infectious diseases2025

Targeting invasion-associated proteins PfSUB2 and PfTRAMP in Plasmodium falciparum: identification of potential inhibitors via molecular docking.

Esther O Okafor, Mercy Bella-Omunagbe, Temitope Elugbadebo, Titilope M Dokunmu, Ezekiel Adebiyi

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esther O OkaforCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria. esther.okaforpgs@stu.cu.edu.ng.
Mercy Bella-OmunagbeDepartment of Biochemistry, Covenant University, Ota, Ogun State, Nigeria.
Temitope ElugbadeboDepartment of Biochemistry, Covenant University, Ota, Ogun State, Nigeria.
Titilope M DokunmuCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria. titilope.dokunmu@covenantuniversity.edu.ng.
Ezekiel AdebiyiDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany. e.adebiyi@dkfz.de.

Funding

WEST AFRICAN SUSTAINABLE LEADERSHIP AND INNOVATION TRAINING IN BIOINFORMATICS RESEARCH (WASLITBRe)U2RTW010679 · FIC · COVENANT UNIVERSITY · PI ADEBIYI, EZEKIEL FEMI, AMOAKO-YIRENKYI, PETER · 2017 to 2021
$1.4M
FIC NIH HHS U2R TW010679NIH HHS 1U2RTW010679
6 · The paper itself

Abstract

Plasmodium falciparum subtilisin-like protease 2 (PfSUB2) is responsible for processing Plasmodium falciparum thrombospondin-related apical merozoite protein (PfTRAMP). These proteins are essential for asexual blood stage growth and RBC invasion and have, therefore, been identified as potential drug targets. This study predicted the three-dimensional structure of PfSUB2 and PfTRAMP and identified potential inhibitors using molecular docking methods. Five hundred nineteen compounds were docked against both proteins with AutoDock Vina in PyRx. Compounds 139,974,934 and 154,414,021 exhibited better binding affinities when compared to the standard inhibitors, PMSF, which highlights them as suitable inhibitors and potential antimalarials targeting PfTRAMP and PfSUB2. It also highlights 155,204,487 as a compound with dual antimalarial target potential, exhibiting a better binding affinity to PfTRAMP and PfSUB2. The study recommends 139,974,934, 154,414,021, and 155,204,487 as possible compounds for antimalarial drug development.

Indexed as

Antiprotozoal AgentsMembrane ProteinsPlasmodium falciparumProtozoan ProteinsSubtilisinsDrug DevelopmentErythrocytesHumansMalaria, FalciparumMolecular Docking SimulationMolecular Targeted TherapyAntiprotozoal AgentsMembrane ProteinsProtozoan ProteinsPTRAMP protein, Plasmodiumsub-2 protein, Plasmodium falciparumSubtilisinsMalariaMolecular DockingPlasmodium falciparumSubtilisin-like protease 2Thrombospondin-related apical merozoite protein

Identifiers

PMID40830840
PMCPMC12366235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.